Bicyclomycin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 8: | Line 8: | ||
===Structure=== | ===Structure=== | ||
[[Image:bicyclomycin structure.gif]] | |||
===Targets=== | ===Targets=== | ||
Revision as of 21:48, 6 October 2011
Bicyclomycin, discovered in 1972, has a structure that is unique among antibiotics. Currently used to treat nonspecific diarrhea, it has a low toxicity, and no cross-resistance with other antibiotics has yet been found. It is effective against many Gram-negative bacteria. [1]
Mode of Action
Bicyclomycin inhibits Rho by being a reversible, noncompetitive inhibitor of ATP. [1]
Structure
Targets
Bicyclomycin targets the transcription termination factor Rho [2]
Mechanisms of Resistance
Mutations that affect sensitivity
Genes in E. coli that affect sensitivity to bicyclomycin. <ref name='PMID:21357484'/
<protect>
| Gene | Allele | Sensitivity to BCM | Reference |
|---|---|---|---|
| edit table |
</protect>
References
See Help:References for how to manage references in EcoliWiki.